Holmes Scott A 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed May 1, 2018
Insider Transaction Report
Form 4
Holmes Scott A
Chief Financial Officer
Transactions
- Sale
Common Stock
2018-04-30$4.67/sh−2,407$11,241→ 170,062 total
Footnotes (2)
- [F1]Sale of a total of 2,407 shares of common stock was made in order to satisfy Mr. Holmes' income tax withholding obligation upon the vesting of 8,228 shares of restricted stock on April 27, 2018. Mr. Holmes had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 90,935 shares of restricted stock.